Page last updated: 2024-10-28

glimepiride and Compensatory Hyperinsulinemia

glimepiride has been researched along with Compensatory Hyperinsulinemia in 3 studies

glimepiride: structure given in first source

Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.

Research Excerpts

ExcerptRelevanceReference
"This study was a post hoc analysis of the CANDLE trial (UMIN000017669), which compared the effect of 24 weeks of treatment with canagliflozin or glimepiride for changes in N-terminal pro-brain natriuretic peptide in patients with T2DM and chronic heart failure (CHF)."8.31Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial. ( Ajioka, M; Hiramitsu, S; Imai, T; Kadokami, T; Node, K; Shimabukuro, M; Suzuki, M; Takahashi, N; Tanaka, A; Yamaguchi, S, 2023)
"This study was a post hoc analysis of the CANDLE trial (UMIN000017669), which compared the effect of 24 weeks of treatment with canagliflozin or glimepiride for changes in N-terminal pro-brain natriuretic peptide in patients with T2DM and chronic heart failure (CHF)."4.31Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial. ( Ajioka, M; Hiramitsu, S; Imai, T; Kadokami, T; Node, K; Shimabukuro, M; Suzuki, M; Takahashi, N; Tanaka, A; Yamaguchi, S, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Yamaguchi, S1
Shimabukuro, M1
Tanaka, A1
Imai, T1
Hiramitsu, S1
Takahashi, N1
Kadokami, T1
Ajioka, M1
Suzuki, M1
Node, K1
Clark, HE1
Matthews, DR1
Balaguer Santamaría, JA1
Feliu Rovira, A1
Escribano Subias, J1
Salvadó Juncosa, O1
Sardá Auré, P1
Gussinyé Canadell, M1

Trials

1 trial available for glimepiride and Compensatory Hyperinsulinemia

ArticleYear
The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1996, Volume: 28, Issue:9

    Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Glucose Clamp Technique; G

1996

Other Studies

2 other studies available for glimepiride and Compensatory Hyperinsulinemia

ArticleYear
Canagliflozin reduces proteinuria by targeting hyperinsulinaemia in diabetes patients with heart failure: A post hoc analysis of the CANDLE trial.
    Diabetes, obesity & metabolism, 2023, Volume: 25, Issue:2

    Topics: Canagliflozin; Chronic Disease; Diabetes Mellitus, Type 2; Heart Failure; Humans; Hyperinsulinism; H

2023
[Persistent hyperinsulinemic hypoglycemia in newborn associated with glimepiride treatment at the beginning of pregnancy].
    Revista clinica espanola, 2000, Volume: 200, Issue:7

    Topics: Adult; Diabetes, Gestational; Female; Humans; Hyperinsulinism; Hypoglycemia; Hypoglycemic Agents; In

2000